Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
TransAlta Corp
TSX:TA
|
CA |
|
LNA Sante SA
PAR:LNA
|
FR |
|
BRP Group Inc
NASDAQ:BWIN
|
US |
|
John Wiley & Sons Inc
NYSE:WLY
|
US |
Wall St Price Targets
RIGL Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RIGL is 51.82 USD with a low forecast of 38.38 USD and a high forecast of 72.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RIGL's stock price target?
Price Target
51.82
USD
According to Wall Street analysts, the average 1-year price target for RIGL is 51.82 USD with a low forecast of 38.38 USD and a high forecast of 72.45 USD.
What is the Revenue forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is -2%.
What is the Operating Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
0%
The compound annual growth rate for Operating Income over the next 8 years is 0%.
What is the Net Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-16%
The compound annual growth rate for Net Income over the next 8 years is -16%.
